Skip to main content
VITRAFY LIFE SCIENCES LIMITED logo

VITRAFY LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · VFY ISIN · AU0000361297 ASX Professional, scientific and technical activities
Open in API
Filings indexed 91 across all filing types
Latest filing 2025-08-04 Investor Presentation
Country AU Australia
Listing ASX VFY

About VITRAFY LIFE SCIENCES LIMITED

https://www.vitrafy.com

Vitrafy Life Sciences Limited specializes in the development and commercialization of advanced cryopreservation technologies designed to optimize the preservation and transport of biological materials. The company provides end-to-end cold chain solutions, focusing on maintaining the viability and functionality of sensitive life science products, including cells, tissues, and organs. Its core technology utilizes precise, automated cooling and warming protocols to minimize cellular damage during the freezing process, addressing critical challenges in regenerative medicine, cell and gene therapy, and biobanking. By integrating hardware, software, and specialized consumables, Vitrafy aims to standardize cryopreservation workflows and improve clinical outcomes through enhanced sample recovery and data-driven monitoring throughout the supply chain.

Recent filings

Filing Released Lang Actions
FY25 Full Year Results Presentation - Amended 29 pages 1.2MB
Investor Presentation Classification · 95% confidence The document is titled 'Financial Results Presentation FY25' and dated 5 August 2025. It is a presentation by Vitrafy Life Sciences Limited, containing operational highlights, market development, technology progress, financial position summary, and management introductions. The content is structured as a presentation with slides, disclaimers, and forward-looking statements. There is no indication that this is a full annual or interim report with detailed financial statements, nor is it a brief earnings release. The document is a detailed presentation aimed at investors summarizing financial results and operational progress for fiscal year 2025. This matches the definition of an Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2025-08-04 English
Expiry of Voluntary Escrow Restrictions 1 page 124.
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 31 July 2025 regarding the expiry of voluntary escrow restrictions on shares, referencing the release of audited accounts for the financial year ended 30 June 2025. The content is brief, focused on a specific capital-related event (escrow expiry) tied to share restrictions, and does not contain financial statements or detailed financial data. It is not the audited accounts themselves but an announcement related to share capital restrictions ceasing. This fits best under Capital/Financing Update (CAP) as it concerns share escrow and capital structure changes.
2025-07-30 English
Q4 FY25 Quarterly Activities Report and Appendix 4C 12 pages 587.6KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 30 July 2025 presenting the Quarterly Activities Report and Appendix 4C Cash Flow report for the fourth quarter ended 30 June 2025 of the financial year 2025. It includes detailed operational highlights, technology development updates, commercialisation progress, financial updates including cash flow statements, and outlook. The presence of the Appendix 4C cash flow report, which is a regulatory quarterly cash flow statement required by ASX Listing Rule 4.7B, confirms this is a quarterly report. The document is comprehensive, contains substantive financial data and analysis for a period shorter than a full fiscal year, and is not merely an announcement of a report or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q4 2025
2025-07-29 English
Appendix 4C, FY25 Annual Results and Investor Call Schedule 1
Report Publication Announcement Classification · 95% confidence The document is an ASX announcement dated 29 July 2025. It states that the company will release its Quarterly Activities Report and Appendix 4C for the quarter ended 30 June 2025 on 30 July 2025, and its FY25 Annual Results & Appendix 4E on 5 August 2025. It also announces an investor webinar to present the results. The document itself does not contain the financial results or detailed report but is an announcement about the upcoming release of these reports and the investor call. The document length is short (2061 characters) and it primarily serves as a notification of report release and event schedule. According to the rules, such documents are classified as Report Publication Announcements (RPA) rather than the reports themselves (like IR or 10-K).
2025-07-28 English
Notification of cessation of securities - VFY 4 pages 14.9KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of certain options (unquoted equity securities) for VITRAFY LIFE SCIENCES LIMITED. It provides specific information about securities that have ceased, reasons for cessation, and updated issued capital figures. The document is a formal announcement related to changes in the company's issued capital, specifically the cessation of securities. It does not contain financial statements, management discussion, or audit information. It is not a report but an official notification of securities cessation, which aligns with announcements about capital changes or share issues. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is 4419 characters, which is consistent with a detailed announcement rather than a full report.
2025-06-24 English
Change of Address 1 page 124.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 30 May 2025 regarding a change of the company's registered office and principal place of business address. It is a brief notice without any financial data, report content, or detailed analysis. The document length is only 1726 characters, indicating it is a short announcement. There is no indication of financial results, management changes, voting results, or other report types. The content fits the category of a general regulatory announcement about company information changes. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2025-05-29 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.